Baird Initiates Coverage On Biohaven with Outperform Rating, Announces Price Target of $58
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Brian Skorney has initiated coverage on Biohaven (NYSE:BHVN) with an Outperform rating and set a price target of $58 for the company's stock.
December 08, 2023 | 10:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biohaven has been given an Outperform rating by Baird analyst Brian Skorney, with a price target of $58, indicating a positive outlook for the stock.
The initiation of coverage by Baird with an Outperform rating typically suggests a bullish view on the stock's potential performance. The price target of $58 implies a significant upside from the current trading price, which could attract investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100